Moderna cancer vaccine shows positive results in melanoma trial
Moderna said its personalized mRNA cancer vaccine lowered the risk of melanoma returning or spreading when used with Keytruda in a late-stage trial.
By the ClickNNY North Country Desk
Moderna said its personalized mRNA cancer vaccine reduced the risk of melanoma returning or spreading in a late-stage trial. The vaccine was tested with Merck’s Keytruda, an immunotherapy treatment, compared with Keytruda alone.
The companies said the treatment could be available as soon as next year if regulators approve it. Because the vaccine is tailored to each patient, producing it on a large scale could be difficult. The results sent Moderna shares sharply higher, with the stock rising as much as 160%.
Reported by ClickNNY and reviewed by an editor before publication.
More from ClickNNY
Guides and features from across the North Country.
ClickNNY Guide · Fort Drum
Fort Drum ERDS: How the Army manages excess equipment
The Army’s Equipment Redistribution and Divestiture Site program helps units redistribute or turn in excess equipment, including a Fort Drum operation that processed 16,426 pieces from April through June 2026.
ClickNNY Guide · Fort Drum
North Country winter driving and snow blower safety: what to know
Fort Drum Safety Office courses and New York guidance offer North Country residents advice on winter driving, vehicle preparation and snow blower operation.
ClickNNY Featured · Technology
Two Flaws, Millions of Websites: Inside the PHP Emergency and Why the Web Keeps Ending Up Here
Governments in Europe pulled websites offline Wednesday, and U.S. officials told anyone who can't patch to do the same. Here's what broke, why the internet keeps landing in this spot, and what North Country businesses, churches and town offices should do today.